// App-Quantinova.ai

: Differences in two-year outcomes according to type of atrial fibrillation: results from the GARFIELD-AF registry

Researchers

Presenter

  • G. Kayani

Principal Investigators

  • F. Misselwitz

  • J. Stepinska

  • A.G.G. Turpie

  • A.K. Kakkar

Medical Centers

  • Thrombosis Research Institute, London, United Kingdom

  • Bayer, Berlin, Germany

  • Institute of Oncology, Warsaw, Poland

  • Thrombosis Research Institute and University College London, London, United Kingdom

Locations

  • United Kingdom

  • Germany

  • Poland

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bayer AG

Result

  • N/A